Susquehanna International Group, LLP Fulcrum Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	SELL	$6.7 - $12.0 $288,100 - $516,000	-43,000 Reduced 68.8%	19,500 $184,000
Q4 2023 Feb 14, 2024	SELL	$3.18 - $6.86 $333,900 - $720,300	-105,000 Reduced 62.69%	62,500 $421,000
Q3 2023 Nov 14, 2023	BUY	$3.25 - $6.08 $378,950 - $708,928	116,600 Added 229.08%	167,500 $743,000
Q2 2023 Aug 11, 2023	BUY	$2.26 - $3.8 $77,291 - $129,960	34,200 Added 204.79%	50,900 $167,000
Q1 2023 May 16, 2023	SELL	$2.83 - $13.99 $6,792 - $33,576	-2,400 Reduced 12.57%	16,700 $47,000
Q4 2022 Feb 14, 2023	BUY	$5.01 - $8.35 $17,034 - $28,390	3,400 Added 21.66%	19,100 $139,000
Q3 2022 Nov 14, 2022	SELL	$4.92 - $9.1 $67,404 - $124,670	-13,700 Reduced 46.6%	15,700 $127,000

135

59.5M

4.32M

307K

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $187M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.